IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,713.60 ▼ 0.64% MERVAL 2,848,945 — — USD/BRL5.94▲ 0.05% USD/MXN19.06▼ 0.11% USD/CLP1,017▲ 0.04% USD/COP3,422▲ 1.93% USD/PEN3.45▼ 0.04% USD/ARS1,562▼ 0.18% USD/UYU40.61▲ 3.19% USD/PYG6,212▲ 2.34% USD/BOB11.64▲ 2.55% USD/DOP59.52▼ 0.80% USD/CRC441.73▲ 2.68% USD/GTQ7.64▲ 3.22% USD/HNL26.89▲ 3.31% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.45% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 2.60% USD/TTD6.70▲ 2.00% EUR/BRL6.52▲ 1.20% BRENT 89.48 ▼ 2.72% WTI 82.44 ▼ 0.93% IRON ORE 161.91 — — COPPER 5.54 ▼ 1.56% GOLD 3,576 ▼ 2.97% SILVER 42.21 ▼ 4.76% SOY 1,213 ▲ 0.41% CORN 450.75 ▲ 2.68% WHEAT 596.00 ▲ 3.07% COFFEE 271.80 ▼ 3.63% SUGAR 16.99 ▼ 0.99% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.55 ▲ 4.74% COCOA 5,230 ▲ 3.30% BEEF 223.00 ▲ 1.47% CATTLE 335.85 ▼ 0.34% LITHIUM 54.33 ▼ 2.23% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74% IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,713.60 ▼ 0.64% MERVAL 2,848,945 — — USD/BRL 5.94 ▲ 0.01% USD/MXN 19.06 ▼ 0.13% USD/CLP 1,016 ▼ 0.09% USD/COP 3,428 ▲ 2.10% USD/PEN 3.45 ▲ 0.17% USD/ARS 1,565 ▲ 0.01% USD/UYU 40.61 ▲ 3.16% USD/PYG 6,212 ▲ 2.34% USD/BOB 11.64 ▲ 3.02% USD/DOP 59.52 ▼ 0.80% USD/CRC 441.73 ▲ 2.68% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.89 ▲ 3.31% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.45% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 2.60% USD/TTD 6.70 ▲ 2.00% EUR/BRL 6.52 ▲ 1.16% BRENT 89.48 ▼ 2.72% WTI 82.44 ▼ 0.93% IRON ORE 161.91 — — COPPER 5.54 ▼ 1.56% GOLD 3,576 ▼ 2.97% SILVER 42.21 ▼ 4.76% SOY 1,213 ▲ 0.41% CORN 450.75 ▲ 2.68% WHEAT 596.00 ▲ 3.07% COFFEE 271.80 ▼ 3.63% SUGAR 16.99 ▼ 0.99% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.55 ▲ 4.74% COCOA 5,230 ▲ 3.30% BEEF 223.00 ▲ 1.47% CATTLE 335.85 ▼ 0.34% LITHIUM 54.33 ▼ 2.23% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74%
since 2009
Friday, November 20, 2026

Covid-19 Brazil

Finnish Scientists Seek Brazil for Coronavirus Vaccine Partnership

By · · 2 min read
Amid concerns that Brazil will interrupt the vaccination campaign for lack of doses, researchers from two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.
Two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.

RIO DE JANEIRO, BRAZIL – Amid concerns that Brazil will interrupt the vaccination campaign for lack of doses, researchers from two universities in Finland sought the Brazilian government to sign a partnership for the development of a new vaccine against the coronavirus.

RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The agreement would serve to conduct phase 3 trials in Brazil between June and July this year. Subsequently, the Finnish universities would provide the technology transfer (teach step by step) for the manufacture of the immunizer in Brazil – the same type of agreement that was signed by the Butantan Institute with SinoVac and the Oswaldo Cruz Foundation (Fiocruz) with AstraZeneca.

The information was confirmed by the Finnish Embassy in Brazil, which approached the Brazilian Embassy in Helsinki.

The vaccine is under development by scientists from the University of Helsinki and the University of Eastern Finland.

The researchers contacted the Brazilian Embassy in Helsinki, and the request was forwarded to the Ministry of Foreign Affairs and the Ministry of Health. Thereafter, the Ministry of Health granted Fiocruz one week to reply to the proposal.

Finland and Brazil are said to be interested in the negotiation and, consequently, the Finnish Embassy called for “urgent action”.

According to the University of Eastern Finland website, the vaccine is being developed using adenovirus viral vector technology – that is, a cold virus is modified to contain a small portion of Sars-Cov-2 and trigger the body’s immune response.

The institution disclosed in April last year that the vaccine would be administered in the form of a nasal spray. The University of Eastern Finland said it has been granted EUR 1 billion for the studies by the Academy of Finland, the Finnish government’s funding body for science.

One of the coordinators of the study, Professor Seppo Ylä-Herttuala, had already been researching the viral vector technology with adenovirus for gene therapy against cancer and cardiovascular diseases.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.